(Q35215147)
Statements
Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics (English)
Lynne M Howells
D P Berry
P J Elliott
E W Jacobson
E Hoffmann
B Hegarty
W P Steward